Burkholderia respiratory tract infections in Italian patients with cystic fibrosis: molecular characterization
- PMID: 16375971
- DOI: 10.1016/j.jinf.2005.11.005
Burkholderia respiratory tract infections in Italian patients with cystic fibrosis: molecular characterization
Abstract
Objectives: To characterize by molecular techniques Burkholderia strains responsible for respiratory tract infections in cystic fibrosis (CF) patients (children and adults), to assign the Burkholderia cepacia complex (Bcc) isolates to a genomovar and to assess the presence of cblA and esmR genes in bacteria. Unique or sequential Burkholderia isolates (n=48) that had been collected from eight CF children and 17 adults over several (4-6) years were investigated; moreover 11 reference strains were analyzed.
Methods: The microorganisms were identified by using biochemical methods, genotyped by pulse field gel electrophoresis (PFGE) and random-amplified polymorphic DNA fingerprinting-PCR (RAPD-PCR), and assessed by PCR assays for the genomovar and cblA and esmR genes of Bcc.
Results: Among isolates 70.8% were identified as Bcc genomovar III-A; one child was infected by Burkholderia ambifaria and four adults were colonized with Burkholderia gladioli. The cblA gene was not detected in any of the isolates, while the esmR gene was detected in the 52.1% of the strains, all belonging to genomovar III-A.
Conclusion: Molecular analysis of strains revealed in CF patients a colonization with a persistent Burkholderia flora with strains of one genotype. The prevalence of Bcc of genomovar III-A in the two categories of patients and of B. gladioli in four adults demonstrated that transmission may have occurred between subjects. Moreover the B. ambifaria infection demonstrated in a child may be environmentally derived.
Similar articles
-
Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis.J Microbiol. 2007 Jun;45(3):275-9. J Microbiol. 2007. PMID: 17618236
-
Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.Res Microbiol. 2003 Sep;154(7):491-8. doi: 10.1016/S0923-2508(03)00145-1. Res Microbiol. 2003. PMID: 14499935
-
Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.APMIS. 2007 Apr;115(4):311-8. doi: 10.1111/j.1600-0463.2007.apm_603.x. APMIS. 2007. PMID: 17504297
-
Burkholderia cepacia complex: impact on the cystic fibrosis lung lesion.Semin Respir Crit Care Med. 2009 Oct;30(5):596-610. doi: 10.1055/s-0029-1238918. Epub 2009 Sep 16. Semin Respir Crit Care Med. 2009. PMID: 19760547 Review.
-
Burkholderia cepacia infection and lung transplantation.Semin Respir Infect. 2002 Dec;17(4):284-90. doi: 10.1053/srin.2002.36443. Semin Respir Infect. 2002. PMID: 12497545 Review.
Cited by
-
Clinical and environmental Burkholderia strains: biofilm production and intracellular survival.Curr Microbiol. 2007 Jun;54(6):440-4. doi: 10.1007/s00284-006-0601-9. Epub 2007 Apr 24. Curr Microbiol. 2007. PMID: 17457645
-
Burkholderia cepacia complex in cystic fibrosis in a Brazilian reference center.Med Microbiol Immunol. 2017 Dec;206(6):447-461. doi: 10.1007/s00430-017-0521-2. Epub 2017 Sep 30. Med Microbiol Immunol. 2017. PMID: 28965239
-
Sphingobacterium respiratory tract infection in patients with cystic fibrosis.BMC Res Notes. 2009 Dec 23;2:262. doi: 10.1186/1756-0500-2-262. BMC Res Notes. 2009. PMID: 20030840 Free PMC article.
-
Phenotypic and genotypic characterization of Pseudomonas aeruginosa from cystic fibrosis patients.Eur J Clin Microbiol Infect Dis. 2008 Nov;27(11):1093-9. doi: 10.1007/s10096-008-0551-1. Epub 2008 May 17. Eur J Clin Microbiol Infect Dis. 2008. PMID: 18488256
-
Burkholderia cepacia complex nasal isolation in immunocompetent patients with sinonasal polyposis not associated with cystic fibrosis.Eur J Clin Microbiol Infect Dis. 2007 Jan;26(1):73-5. doi: 10.1007/s10096-006-0233-9. Eur J Clin Microbiol Infect Dis. 2007. PMID: 17180349 No abstract available.